Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
9.47
+0.51 (5.69%)
Feb 18, 2026, 4:00 PM EST - Market closed
Quoin Pharmaceuticals Employees
As of December 31, 2024, Quoin Pharmaceuticals had 5 total employees, including 3 full-time and 2 part-time employees. The number of employees increased by 1 or 25.00% compared to the previous year.
Employees
5
Change (1Y)
1
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$2,753,511
Market Cap
7.95M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 5 | 1 | 25.00% | 3 | 2 |
| Dec 31, 2023 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2022 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2021 | 4 | 2 | 100.00% | 4 | 0 |
| Dec 31, 2020 | 2 | - | - | 2 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 117 |
| Aptevo Therapeutics | 37 |
| NuCana | 22 |
| Kiora Pharmaceuticals | 12 |
| Revelation Biosciences | 9 |
| TransCode Therapeutics | 7 |
| Immuron | 7 |
| Addex Therapeutics | 2 |
QNRX News
- 22 days ago - Quoin Pharmaceuticals Announces Submission to Japanese MHLW for Orphan Drug Designation for QRX003 in Netherton Syndrome - GlobeNewsWire
- 4 weeks ago - Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome - GlobeNewsWire
- 3 months ago - Quoin Pharmaceuticals Announces Corporate Update and Third Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - Quoin Pharmaceuticals to Provide Corporate Update and Announce Third Quarter 2025 Financial Results on Thursday, November 6, 2025 - GlobeNewsWire
- 4 months ago - Crude Oil Falls Over 4%; Quoin Pharmaceuticals Shares Spike Higher - Benzinga
- 4 months ago - Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million - GlobeNewsWire
- 5 months ago - Quoin Pharmaceuticals Releases Fifth NETHERTON NOW Video Featuring Writers and Influencers Allie and Kaleigh Fasanella, Twin Sisters Living with Netherton Syndrome - GlobeNewsWire
- 6 months ago - Quoin Pharmaceuticals Appoints New Chief Financial Officer to Support Commercialization Strategy - GlobeNewsWire